GSK, Pfizer combining efforts to boost role in AIDS market

04/16/2009 | Bloomberg

GlaxoSmithKline and Pfizer are forming a company to combine their HIV-drug businesses, hoping to gain a nearly 20% share of the $12.3 billion AIDS market that Gilead Sciences dominates. GSK will take control of 85% of the firm, which will own 11 medicines on the market and six experimental treatments.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA